Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;14(1):42-44.
doi: 10.15420/icr.2018.21.3.

Device-Related Thrombus After Left Atrial Appendage Closure

Philippe Garot  1 , Bertrand Cormier  1 , Jérôme Horvilleur  1
Affiliations
Review

Device-Related Thrombus After Left Atrial Appendage Closure

Philippe Garot et al. Interv Cardiol. 2019 Feb.

Abstract

Although left atrial appendage closure (LAAC) has proved non-inferior to oral anticoagulants in patients with AF, there has been recent concern about the occurrence of late complications, especially device-related thrombus (DRT), which was associated with increased risk of stroke. In this article, the incidence, risk factors and time course of DRT after LAAC are discussed, as well as the potential benefits of dedicated strategies in the management of DRT, which remain speculative, especially in patients with a contraindication to oral anticoagulants. In these patients, decision-making should be based on a multidisciplinary evaluation of the ischaemic/bleeding balance on an individual basis.

Keywords: Complications; device-related thrombus; left atrial appendage closure; outcomes; stroke; thrombus.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

References

    1. Holmes DR, Reddy VY, Turi ZG et al. PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42. doi: 10.1016/S0140-6736(09)61343-X. - DOI - PubMed
    1. Dukkipati SR, Kar S, Holmes DR, Jr et al. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018;138:874–85. doi: 10.1161/CIRCULATIONAHA.118.035090. - DOI - PubMed
    1. Holmes DR, Jr, Kar S, Price MJ et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12. doi: 10.1016/j.jacc.2014.04.029. - DOI - PubMed
    1. Reddy VY, Holmes D, Doshi SK et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123:417–24. doi: 10.1161/CIRCULATIONAHA.110.976449. - DOI - PubMed
    1. Holmes DR, Jr, Doshi SK, Kar S et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65:2614–23. doi: 10.1016/j.jacc.2015.04.025. - DOI - PubMed